About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Biomarkers for Post-COVID Conditions | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05196516

Biomarkers for Post-COVID Conditions

The COVID-19 infection affects humans differently. While some recover quickly and fully, others develop serious illnesses and late complications. The term late complications describe symptoms that las...

Lead sponsor: Zealand University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Zealand University Hospital

Collaborators

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Skane University Hospital

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18 to 65 years
•SARS-CoV-2 infection proven by a PCR test at least 12 weeks prior to inclusion
•Only cases: Referred to the Clinic of post-COVID conditions located in Region Zealand, Denmark

Exclusion Criteria

•Need of being on a respirator during infection with SARS-CoV-2
•Only controls: complain about long covid 12 weeks or more after proven infection with SARS-CoV-2

Related studies

Cognitive-Sensorimotor Function in Long-COVID

NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection

Effects Of Dietary Fats on Gut Microbiota Composition and Metabolic Activity in Healthy Adults

NCT07550023 · Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition, and more

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213 · Adenovirus Infection, BK Virus Infection, and more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment208

Start dateJan 2022

Last updatedFeb 11, 2025

Condition

COVID-19 SARS-CoV-2 Biomarkers Post-acute COVID-19 Syndrome

Locations shown

Zealand University Hospital

Roskilde, Region Sjælland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions